Refine
Has Fulltext
- yes (22)
Is part of the Bibliography
- yes (22)
Year of publication
- 2022 (22) (remove)
Document Type
- Journal article (16)
- Doctoral Thesis (4)
- Preprint (2)
Keywords
- X-ray crystallography (3)
- ischemic stroke (3)
- glycoprotein VI (2)
- AAA+ ATPase p97 (1)
- ADAM10 (1)
- ADP-ribosyltransferases (1)
- Antikörper (1)
- Arp2/3 complex (1)
- Autoantigen (1)
- CXCL4 (1)
- CXCL7 (1)
- Caspr1 (1)
- Chylomicron (1)
- Chylomicrons (1)
- Clostridioides binary toxins (1)
- Contactin 1 (1)
- Cortactin (1)
- Crystal structure of MTR1 (1)
- Darm (1)
- EHT1864 (1)
- ERK1/2 (1)
- Epitop (1)
- FoxO3 (1)
- G-protein-coupled receptors (1)
- GPCRs (1)
- GPVI (1)
- GPVI shedding (1)
- GapN (1)
- HHV-6A (1)
- Herpesvirus (1)
- JAQ1 (1)
- Methyltransferase Ribozyme MTR1 (1)
- Microarray (1)
- NADPH (1)
- NAP-2 (1)
- Neurofascin (1)
- Neutralisation <Chemie> (1)
- Obesity (1)
- Orai2 (1)
- PF4 (1)
- PNA (peptide nucleic acid) (1)
- Protein Kinase D2 (1)
- Proteinkinase D (1)
- RKIP (1)
- RNA (1)
- RNA-catalyzed RNA methylation (1)
- Rac1 (1)
- Ranvier-Schnürring (1)
- Rho GTPase (1)
- TRRAP (1)
- Transcription (1)
- TspanC8 (1)
- actin (1)
- antibody (1)
- atomic force microscopy (1)
- autoantigen (1)
- autoinhibition (1)
- biased signaling (1)
- biosensor (1)
- chemokines (1)
- combinatorial libraries (1)
- computational docking (1)
- dSTORM (1)
- drug target (1)
- ectodomain cleavage (1)
- enzyme mechanisms (1)
- epitope (1)
- fine-mapping (1)
- fluorescence resonance energy transfer (FRET) (1)
- fragment screening (1)
- fusion and fission (1)
- gephyrin (1)
- glycolytic flux control (1)
- glycoprotein receptor Ibα (1)
- guanine nucleotide exchange factor (GEF) (1)
- homology modeling (1)
- inhibitory postsynapse (1)
- intrinsic metabolism (1)
- ischemic penumbra (1)
- kinetics (1)
- latency (1)
- matrix metalloproteinase (1)
- metalloproteinase (1)
- miR-30 (1)
- miRNA processing (1)
- middle cerebral artery occlusion (1)
- mitochondria (1)
- molecular mobility (1)
- neutralization (1)
- parathyroid hormone 1 receptor (1)
- peptides (1)
- phosphoglycolate phosphatase (1)
- phospholipase C gamma 2 (1)
- platelet (1)
- platelet activation (1)
- platelet inhibition (1)
- platelet receptors (1)
- platelets (1)
- post-translational modifications (1)
- protein-DNA interactions (1)
- screening (1)
- shedding (1)
- tMCAO (1)
- temporal range (1)
- tetraspanin (1)
- thermodynamics (1)
- thrombo-inflammation (1)
- transcription factors (1)
- type I interferon (1)
- virus reactivation (1)
- Übergewicht (1)
Institute
- Rudolf-Virchow-Zentrum (22) (remove)
Sonstige beteiligte Institutionen
RNA-catalysed RNA methylation was recently shown to be part of the catalytic repertoire of ribozymes. The methyltransferase ribozyme MTR1 catalyses the site-specific synthesis of 1-methyladenosine (m\(^1\)A) in RNA, using O\(^6\)-methylguanine (m\(^6\)G) as methyl group donor. Here we report the crystal structure of MTR1 at a resolution of 2.8 Å, which reveals a guanine binding site reminiscent of natural guanine riboswitches. The structure represents the postcatalytic state of a split ribozyme in complex with the m1A-containing RNA product and the demethylated cofactor guanine. The structural data suggest the mechanistic involvement of a protonated cytidine in the methyl transfer reaction. A synergistic effect of two 2'-O-methylated ribose residues in the active site results in accelerated methyl group transfer. Supported by these results, it seems plausible that modified nucleotides may have enhanced early RNA catalysis and that metabolite-binding riboswitches may resemble inactivated ribozymes that have lost their catalytic activity during evolution.
Protein kinase D2 drives chylomicron-mediate lipid transport in the intestine and promotes obesity
(2022)
Obesity and associated metabolic syndrome are growing concerns in modern society due to the negative consequences for human health and well-being. Cardiovascular diseases and type 2 diabetes are only some of the pathologies associated to overweight. Among the main causes are decreased physical activity and food availability and composition. Diets with high content of fat are energy-dense and their overconsumption leads to an energy imbalance, which ultimately promotes energy storage as fat and obesity. Aberrant activation of signalling cascades and hormonal imbalances are characteristic of this disease and members of the Protein Kinase D (PKD) family have been found to be involved in several mechanisms mediating metabolic homeostasis. Therefore, we aimed to investigate the role of Protein Kinase D2 (PKD2) in the regulation of metabolism. Our investigation initiated with a mice model for global PKD2 inactivation, which allowed us to prove a direct involvement of this kinase in lipids homeostasis and obesity. Inactivation of PKD2 protected the mice from high-fat diet-induced obesity and improved their response to glucose, insulin and lipids. Furthermore, the results indicated that, even though there were no changes in energy intake or expenditure, inactivation of PKD2 limited the absorption of fat from the intestine and promoted energy excretion in feces. These results were verified in a mice model for specific deletion of intestinal PKD2. These mice not only displayed an improved metabolic fitness but also a healthier gut microbiome profile. In addition, we made use of a small-molecule inhibitor of PKD in order to prove that local inhibition of PKD2 in the intestine was sufficient to inhibit lipid absorption. The usage of the inhibitor not only protected the mice from obesity but also was efficient in avoiding additional body-weight gain after obesity was pre-established in mice. Mechanistically, we determined that PKD2 regulates lipids uptake in enterocytes by phosphorylation of Apolipoprotein A4 (APOA4) and regulation of chylomicron-mediated triglyceride absorption. PKD2 deletion or inactivation increased abundance of APOA4 and decreased the size of chylomicrons and therefore lipids absorption from the diet. Moreover, intestinal activation of PKD2 in human obese patients correlated with higher levels of triglycerides in circulation and a detrimental blood profile. In conclusion, we demonstrated that PKD2 is a key regulator of dietary fat absorption in murine and human context, and its inhibition might contribute to the treatment of obesity.